Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

Similar articles for PubMed (Select 18026102)

1.

Cystatin C modulates cerebral beta-amyloidosis.

Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M.

Nat Genet. 2007 Dec;39(12):1437-9. Epub 2007 Nov 18.

PMID:
18026102
2.

Cystatin C for therapeutic drug monitoring.

Rebollo N, Cepeda-Piorno FJ.

Clin Chem. 2015 Jun;61(6):804-7. doi: 10.1373/clinchem.2014.225847. Epub 2015 May 29. No abstract available.

PMID:
26025947
3.

Endogenous aggregates of amyloidogenic cystatin C variant are removed by THP-1 cells in vitro and induce differentiation and a proinflammatory response.

Jonsdottir G, Ingolfsdottir IE, Thormodsson FR, Petersen PH.

Neurobiol Aging. 2013 May;34(5):1389-96. doi: 10.1016/j.neurobiolaging.2012.11.012. Epub 2012 Dec 25.

PMID:
23273574
4.

Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C.

Orlikowska M, Jankowska E, Kołodziejczyk R, Jaskólski M, Szymańska A.

J Struct Biol. 2011 Feb;173(2):406-13. doi: 10.1016/j.jsb.2010.11.009. Epub 2010 Nov 11.

PMID:
21074623
5.

Crystal structure of human cystatin C stabilized against amyloid formation.

Kolodziejczyk R, Michalska K, Hernandez-Santoyo A, Wahlbom M, Grubb A, Jaskolski M.

FEBS J. 2010 Apr;277(7):1726-37. doi: 10.1111/j.1742-4658.2010.07596.x. Epub 2010 Feb 19.

PMID:
20175878
6.

Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.

Biscaro B, Lindvall O, Hock C, Ekdahl CT, Nitsch RM.

J Neurosci. 2009 Nov 11;29(45):14108-19. doi: 10.1523/JNEUROSCI.2055-09.2009.

7.

Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease.

Ghidoni R, Paterlini A, Albertini V, Glionna M, Monti E, Schiaffonati L, Benussi L, Levy E, Binetti G.

Neurobiol Aging. 2011 Aug;32(8):1435-42. doi: 10.1016/j.neurobiolaging.2009.08.013. Epub 2009 Sep 20.

8.
9.

Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.

Philipson O, Lannfelt L, Nilsson LN.

FEBS Lett. 2009 Sep 17;583(18):3021-6. doi: 10.1016/j.febslet.2009.08.009. Epub 2009 Aug 14.

10.

Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.

Martone RL, Zhou H, Atchison K, Comery T, Xu JZ, Huang X, Gong X, Jin M, Kreft A, Harrison B, Mayer SC, Aschmies S, Gonzales C, Zaleska MM, Riddell DR, Wagner E, Lu P, Sun SC, Sonnenberg-Reines J, Oganesian A, Adkins K, Leach MW, Clarke DW, Huryn D, Abou-Gharbia M, Magolda R, Bard J, Frick G, Raje S, Forlow SB, Balliet C, Burczynski ME, Reinhart PH, Wan HI, Pangalos MN, Jacobsen JS.

J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.

11.

Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.

Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, Carro E.

Neurobiol Dis. 2009 Oct;36(1):42-50. doi: 10.1016/j.nbd.2009.06.018. Epub 2009 Jul 14.

PMID:
19607917
12.

Gangliosides determine the amyloid pathology of Alzheimer's disease.

Oikawa N, Yamaguchi H, Ogino K, Taki T, Yuyama K, Yamamoto N, Shin RW, Furukawa K, Yanagisawa K.

Neuroreport. 2009 Aug 5;20(12):1043-6. doi: 10.1097/WNR.0b013e32832e4b9d.

PMID:
19590389
13.

Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.

Bürger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E, Yafai Y, Schliebs R.

Int J Dev Neurosci. 2009 Oct;27(6):517-23. doi: 10.1016/j.ijdevneu.2009.06.011. Epub 2009 Jul 7.

PMID:
19589380
14.

The emerging role of cystatins in Alzheimer's disease.

Zerovnik E.

Bioessays. 2009 Jun;31(6):597-9. doi: 10.1002/bies.200900012.

PMID:
19382231
15.
16.

GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.

Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Sheng S, Wang P, Ren Y, Wang R, Wang Y.

Curr Alzheimer Res. 2009 Apr;6(2):118-31.

PMID:
19355846
17.

Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.

Zhao L, Lin S, Bales KR, Gelfanova V, Koger D, Delong C, Hale J, Liu F, Hunter JM, Paul SM.

J Neurosci. 2009 Mar 18;29(11):3603-12. doi: 10.1523/JNEUROSCI.5302-08.2009.

18.

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.

Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG.

Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1213-21. doi: 10.1007/s00417-009-1060-3. Epub 2009 Mar 7.

PMID:
19271231
19.
20.

Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice.

Takechi R, Galloway S, Pallebage-Gamarallage M, Wellington C, Johnsen R, Mamo JC.

Histochem Cell Biol. 2009 May;131(5):661-6. doi: 10.1007/s00418-009-0567-3. Epub 2009 Feb 19.

PMID:
19225804
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk